The gut microbiome: A line of defense against tuberculosis development
Frontiers in Cellular and Infection Microbiology · 18.04.2023 · 13
DOI: 10.3389/fcimb.2023.1149679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.04.2023. Verfasst von Ziqi Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Munich Medical Research School, Ludwig Maximilian University of Munich (LMU), Munich, Germany. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Tuberculosis, Pulmonary, Mycobacterium tuberculosis, Microbiota. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, China Scholarship Council.
Abstract (Originalsprache)
The tuberculosis (TB) burden remains a significant global public health concern, especially in less developed countries. While pulmonary tuberculosis (PTB) is the most common form of the disease, extrapulmonary tuberculosis, particularly intestinal TB (ITB), which is mostly secondary to PTB, is also a significant issue. With the development of sequencing technologies, recent studies have investigated the potential role of the gut microbiome in TB development. In this review, we summarized studies investigating the gut microbiome in both PTB and ITB patients (secondary to PTB) compared with healthy controls. Both PTB and ITB patients show reduced gut microbiome diversity characterized by reduced Firmicutes and elevated opportunistic pathogens colonization; Bacteroides and Prevotella were reported with opposite alteration in PTB and ITB patients. The alteration reported in TB patients may lead to a disequilibrium in metabolites such as short-chain fatty acid (SCFA) production, which may recast the lung microbiome and immunity via the “gut-lung axis”. These findings may also shed light on the colonization of Mycobacterium tuberculosis in the gastrointestinal tract and the development of ITB in PTB patients. The findings highlight the crucial role of the gut microbiome in TB, particularly in ITB development, and suggest that probiotics and postbiotics might be useful supplements in shaping a balanced gut microbiome during TB treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Munich Medical Research School, Ludwig Maximilian University of Munich (LMU), Munich, Germany.
- Department of Gastroenterology and Hepatology, the First Affiliated Hospital of Nanchang Medical College, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- China Scholarship Council
Zitieren
APA
Yu, Z., Shen, X., Wang, A., Hu, C., & Chen, J. (2023). The gut microbiome: A line of defense against tuberculosis development. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1149679
Vancouver
Yu Z, Shen X, Wang A, Hu C, Chen J. The gut microbiome: A line of defense against tuberculosis development. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1149679
BibTeX
@article{Yu2023,
author = {Yu, Ziqi and Shen, Xiang and Wang, Aiyao and Hu, Chong and Chen, Jianyong},
title = {The gut microbiome: A line of defense against tuberculosis development},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1149679}
}
EUVIMED